The use of Karnofsky Performance Status (KPS) as a predictor of 3 month post discharge mortality in cirrhotic patients

@article{Khalid2018TheUO,
  title={The use of Karnofsky Performance Status (KPS) as a predictor of 3 month post discharge mortality in cirrhotic patients},
  author={Muhammad Ali Khalid and Inamullah Khan Achakzai and Shoaib Ahmed Khan and Zain Majid and Farina Hanif and Javed Iqbal and Syed Mudassir Laeeq and Nasir Hassan Luck},
  journal={Gastroenterology and Hepatology From Bed to Bench},
  year={2018},
  volume={11},
  pages={301 - 305},
  url={https://api.semanticscholar.org/CorpusID:53289915}
}
KPS can be utilized to identify cirrhotic patients at risk of 3-month post discharge mortality, and showed statistical significance on univariate analysis and on multivariate analysis.

Tables from this paper

Karnofsky performance status predicts outcomes in candidates for simultaneous liver‐kidney transplant

Frailty, as assessed by KPS, is associated with poor outcomes in SLKT pre‐ and post‐transplant and was also associated with increased liver and kidney graft losses and with hospital length of stay.

Impact of Physical Function on 1-Year Kidney Transplant Outcomes

Patients needing none or some assistance did not demonstrate a significant difference in 1-year graft failure in either deceased or living donor transplantation, and death for those needing total assistance in deceased donor kidney transplantation was the same.

Desire for hastened death in advanced cancer: cross-sectional study in China

The data provide a theoretical basis for the early detection and diagnosis of the desire to accelerate death of patients with advanced cancer.

Analysis of heart rate variability and accelerometry in patients following surgery for the treatment of gastrointestinal cancer

Early mobilization for patients following surgery for the treatment of gastrointestinal cancer can be performed without increasing HRV and with energy expenditure and IPA similar to those found in patients without cancer.

Outcome measures in neurosurgery: Is a unified approach better? A literature review

Outcome measures in neurosurgery, including mRS, GOS, and KPS, are widely utilized assessment tools for patients’ outcomes in various neurosurgical specialties and a unified global measure may offer solutions with ease of use and application; however, there are limitations.

Excess Body Weight and Cancer-Related Fatigue, Systemic Inflammation, and Serum Lipids in Breast Cancer Survivors

Obese breast cancer survivors had greater levels of CRF, inflammatory markers and certain fatty acids, and inflammatory markers and fatty acids were not found to have any mediating or positive association with CRF variables in this analysis.

Apatinib combined with three-dimensional conformal radiotherapy can prolong advanced gastric cancer patients’ survival times and improve their quality of life

Apatinib combined with 3D-CRT can improve tumor markers and the quality of life, reduce the inflammatory response, and prolong the survival times of advanced gastric cancer patients.

Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects

Cisplatin combined with capecitabine-induced chemotherapy for local NPC can improve the quality of life and reduce the toxic and side effects.

Exosomal microRNA-210 is a potentially non-invasive biomarker for the diagnosis and prognosis of glioma.

Serum levels of exo-miR-210 may serve as a diagnostic, prognostic and hypoxic biomarker to reflect glioma status and hypoxia signatures in patients withglioma.

A Karnofsky performance status–based score predicts death after hospital discharge in patients with cirrhosis

Cirrhosis patients at risk for 3‐month postdis discharge mortality can be identified using a novel KPS‐based score; this score may be adopted in practice to guide postdischarge early interventions, including the integrated provision of active and palliative management strategies.

Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis

Readily available, standardized measures of frailty predict 90‐day mortality, length of stay, and rehabilitation needs for hospitalized patients with cirrhosis.

A model to predict survival in patients with end‐stage liver disease

The MELD scale is a reliable measure of mortality risk in patients with end‐stage liver disease and suitable for use as a disease severity index to determine organ allocation priorities in patient groups with a broader range of disease severity and etiology.

A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale

Frailty is strongly and independently associated with an increased risk of unplanned hospitalization or death in outpatients with cirrhosis and is a rapid screen that could be easily adopted in liver clinics to identify those at highest risk of adverse events.

Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end‐stage liver disease (NACSELD) experience

Potentially preventable second infections are predictors of mortality independent of liver disease severity in this multicenter cirrhosis cohort.

Association between frailty and 30-day outcomes after discharge from hospital

Frailty was common and associated with a substantially increased risk of early readmission or death after discharge from medical wards, and could be useful in identifying high-risk patients being discharged from general internal medicine wards.

Selecting an optimal prognostic system for liver cirrhosis: the model for end‐stage liver disease and beyond

The mortality rates of transplant candidates on the waiting list have remarkably decreased after the implementation of the MELD, and several MELD‐derived prognostic models that incorporate serum Na into calculation have been proposed in the hopes of further improving the model for end‐stage liver disease's prognostic accuracy.